Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GSK GSK	$38.48 -1.2%	$38.94	$31.72 ▼ $44.67	$78.77B	0.5	5.23 million shs	3.60 million shs
HCA HCA Healthcare	$378.62 -2.8%	$369.16	$289.98 ▼ $417.14	$91.08B	1.47	1.61 million shs	789,357 shs
HUM Humana	$243.03 -3.8%	$241.77	$212.45 ▼ $406.46	$29.33B	0.44	1.72 million shs	1.93 million shs
MCK McKesson	$708.97 -2.6%	$712.79	$464.42 ▼ $736.96	$88.71B	0.48	924,329 shs	402,531 shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GSK GSK	+1.41%	+0.69%	-5.14%	+3.35%	+1.41%
HCA HCA Healthcare	+1.72%	+2.84%	+2.24%	+12.18%	+23.70%
HUM Humana	+3.31%	+5.77%	+8.36%	-4.83%	-32.43%
MCK McKesson	-0.90%	+0.60%	+0.84%	+4.58%	+23.80%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GSK GSK	2.0376 of 5 stars	1.1	4.0	2.5	0.0	1.9	0.0	2.5
HCA HCA Healthcare	4.8135 of 5 stars	2.4	3.0	2.5	4.5	3.4	2.5	2.5
HUM Humana	4.6482 of 5 stars	3.2	3.0	2.5	3.9	2.8	1.7	1.3
MCK McKesson	4.7184 of 5 stars	2.4	5.0	3.3	3.0	2.9	2.5	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GSK GSK	2.10	Hold	$37.38	-2.88% Downside
HCA HCA Healthcare	2.74	Moderate Buy	$395.71	4.51% Upside
HUM Humana	2.30	Hold	$280.76	15.53% Upside
MCK McKesson	2.86	Moderate Buy	$696.42	-1.77% Downside

Current Analyst Ratings Breakdown

Latest HCA, HUM, MCK, and GSK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/23/2025	HCA HCA Healthcare	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$376.00 ➝ $404.00
6/17/2025	HUM Humana	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$320.00 ➝ $260.00
6/17/2025	HUM Humana	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Hold ➝ Hold	$305.00 ➝ $280.00
6/12/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$273.00 ➝ $268.00
6/11/2025	MCK McKesson	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$745.00 ➝ $770.00
6/9/2025	HCA HCA Healthcare	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$355.00 ➝ $410.00
6/3/2025	GSK GSK	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
6/3/2025	MCK McKesson	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Equal Weight ➝ Equal Weight	$691.00 ➝ $766.00
6/2/2025	HCA HCA Healthcare	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/2/2025	HCA HCA Healthcare	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Overweight ➝ Overweight	$366.00 ➝ $416.00
6/2/2025	HUM Humana	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$322.00 ➝ $273.00

(Data available from 7/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GSK GSK	$40.10B	1.97	$5.59 per share	6.88	$8.07 per share	4.77
HCA HCA Healthcare	$70.60B	1.29	$35.48 per share	10.67	$2.19 per share	172.89
HUM Humana	$117.76B	0.25	$23.73 per share	10.24	$136.57 per share	1.78
MCK McKesson	$359.05B	0.25	$37.59 per share	18.86	($13.52) per share	-52.44

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GSK GSK	$3.29B	$1.94	19.83	8.28	1.34	9.89%	48.82%	11.15%	7/30/2025 (Estimated)
HCA HCA Healthcare	$5.76B	$22.49	16.84	13.51	1.32	8.07%	1,063.91%	10.10%	7/22/2025 (Estimated)
HUM Humana	$1.21B	$14.14	17.19	18.51	1.84	1.42%	14.47%	5.03%	7/30/2025 (Estimated)
MCK McKesson	$3.30B	$25.83	27.45	19.35	1.46	0.92%	-201.12%	5.83%	8/6/2025 (Estimated)

Latest HCA, HUM, MCK, and GSK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2025	Q2 2025	GSK GSK	$1.12	N/A	N/A	N/A	$7.92 billion	N/A
7/30/2025	Q2 2025	HUM Humana	$6.32	N/A	N/A	N/A	$31.85 billion	N/A
7/22/2025	Q2 2025	HCA HCA Healthcare	$6.20	N/A	N/A	N/A	$18.49 billion	N/A
5/8/2025	Q4 2025	MCK McKesson	$9.83	$10.12	+$0.29	$10.01	$94.00 billion	$90.82 billion
4/30/2025	Q1 2025	GSK GSK	$1.08	$1.13	+$0.05	$1.00	$7.52 billion	$10.06 billion
4/30/2025	Q1 2025	HUM Humana	$10.07	$11.58	+$1.51	$10.30	$32.00 billion	$32.11 billion
4/25/2025	Q1 2025	HCA HCA Healthcare	$5.75	$6.45	+$0.70	$6.45	$18.26 billion	$18.32 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GSK GSK	$1.69	4.39%	N/A	87.11%	N/A
HCA HCA Healthcare	$2.88	0.76%	N/A	12.81%	6 Years
HUM Humana	$3.54	1.46%	N/A	25.04%	N/A
MCK McKesson	$2.84	0.40%	N/A	10.99%	17 Years

Latest HCA, HUM, MCK, and GSK Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/17/2025	HUM Humana	quarterly	$0.8850	1.24%	6/27/2025	6/27/2025	7/25/2025
5/2/2025	GSK GSK	quarterly	$0.4216	4.1%	5/16/2025	5/16/2025	7/10/2025
5/1/2025	MCK McKesson	quarterly	$0.71	0.4%	6/2/2025	6/2/2025	7/1/2025
4/25/2025	HCA HCA Healthcare	quarterly	$0.72	0.84%	6/16/2025	6/16/2025	6/30/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GSK GSK	1.21	0.87	0.58
HCA HCA Healthcare	69.07	1.19	1.06
HUM Humana	0.71	1.91	1.91
MCK McKesson	N/A	0.90	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GSK GSK	15.74%
HCA HCA Healthcare	62.73%
HUM Humana	92.38%
MCK McKesson	85.07%

Insider Ownership

Company	Insider Ownership
GSK GSK	10.00%
HCA HCA Healthcare	1.30%
HUM Humana	0.37%
MCK McKesson	0.11%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GSK GSK	68,629	2.05 billion	1.84 billion	Optionable
HCA HCA Healthcare	316,000	240.57 million	237.45 million	Optionable
HUM Humana	65,680	120.69 million	120.25 million	Optionable
MCK McKesson	45,000	125.11 million	125.01 million	Optionable

HCA, HUM, MCK, and GSK Headlines

Recent News About These Companies

These Top 4 Women-Run Company Stocks Are Quietly Beating the Market

4 hours ago | zacks.com

Q4 Earnings Forecast for McKesson Issued By Leerink Partnrs

July 2 at 8:44 AM | marketbeat.com

WCM Investment Management LLC Acquires 603 Shares of McKesson Corporation (NYSE:MCK)

July 2 at 8:25 AM | marketbeat.com

Oregon Pacific Wealth Management LLC Purchases New Position in McKesson Corporation (NYSE:MCK)

July 2 at 7:41 AM | marketbeat.com

Yukon Wealth Management Inc. Purchases Shares of 1,065 McKesson Corporation (NYSE:MCK)

July 2 at 6:58 AM | marketbeat.com

Is McKesson (MCK) a Solid Growth Stock? 3 Reasons to Think "Yes"

July 1 at 1:45 PM | zacks.com

Zacks.com featured highlights include Agnico Eagle Mines, NetEase, Qifu Technology, UGI and McKesson

July 1 at 12:05 PM | finance.yahoo.com

Summit Trail Advisors LLC Acquires 603 Shares of McKesson Corporation (NYSE:MCK)

July 1 at 8:47 AM | marketbeat.com

McKesson Corporation (NYSE:MCK) Shares Acquired by Smith Group Asset Management LLC

July 1 at 8:10 AM | marketbeat.com

Vontobel Holding Ltd. Lowers Stock Holdings in McKesson Corporation (NYSE:MCK)

July 1 at 7:45 AM | marketbeat.com

WHO NEEDS THE FCC?: Court Holds Cell Numbers Are Residential Numbers for DNC Purposes in First Post-McKesson TCPA Ruling

July 1 at 7:03 AM | natlawreview.comN

Red Door Wealth Management LLC Makes New Investment in McKesson Corporation (NYSE:MCK)

July 1 at 5:58 AM | marketbeat.com

Allspring Global Investments Holdings LLC Sells 12,890 Shares of McKesson Corporation (NYSE:MCK)

July 1 at 4:35 AM | marketbeat.com

The Supreme Court Reins in Agency Power Again: What McKesson Means for TCPA Litigation

June 30 at 9:02 PM | natlawreview.comN

5 Top-Ranked Dividend Growth Stock Picks for the Second Half of 2025

June 30 at 11:00 AM | zacks.com

McKesson Corporation (NYSE:MCK) Shares Acquired by MorganRosel Wealth Management LLC

June 30 at 8:17 AM | marketbeat.com

Canandaigua National Bank & Trust Co. Sells 392 Shares of McKesson Corporation (NYSE:MCK)

June 30 at 7:57 AM | marketbeat.com

Red Cedar Investment Management LLC Takes $867,000 Position in McKesson Corporation (NYSE:MCK)

June 30 at 7:50 AM | marketbeat.com

New York State Teachers Retirement System Sells 7,665 Shares of McKesson Corporation (NYSE:MCK)

June 30 at 6:41 AM | marketbeat.com

Amalgamated Bank Sells 470 Shares of McKesson Corporation (NYSE:MCK)

June 30 at 6:32 AM | marketbeat.com

Mirae Asset Global Investments Co. Ltd. Acquires 3,542 Shares of McKesson Corporation (NYSE:MCK)

June 30 at 4:26 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

Why BigBear.ai Could Rally 100% and Catch Palantir Soon
By Gabriel Osorio-Mazilli | June 30, 2025
View Why BigBear.ai Could Rally 100% and Catch Palantir Soon
IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
By Dan Schmidt | June 20, 2025
View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s Surge
BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
By Gabriel Osorio-Mazilli | June 23, 2025
View BigBear.ai Poised to Benefit as Palantir Dominates AI Defense
Hims & Hers Stock: Buy the Dip or Wait It Out?
By Gabriel Osorio-Mazilli | June 5, 2025
View Hims & Hers Stock: Buy the Dip or Wait It Out?
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?
By Leo Miller | June 19, 2025
View Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars?

HCA, HUM, MCK, and GSK Company Descriptions

GSK NYSE:GSK

$38.48 -0.47 (-1.20%)

As of 03:32 PM Eastern

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

HCA Healthcare NYSE:HCA

$378.62 -10.91 (-2.80%)

As of 03:32 PM Eastern

HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.

Humana NYSE:HUM

$243.03 -9.55 (-3.78%)

As of 03:32 PM Eastern

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

McKesson NYSE:MCK

$708.97 -18.77 (-2.58%)

As of 03:32 PM Eastern

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time